The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEfg-hold.gdr S Regulatory News (EFGD)

Share Price Information for Efg-hold.gdr S (EFGD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.70
Bid: 0.00
Ask: 0.725
Change: 0.00 (0.00%)
Spread: 0.725 (0.00%)
Open: 0.70
High: 0.00
Low: 0.00
Prev. Close: 0.70
EFGD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IFRS Consolidated Financial Statements- FY22

28 Apr 2023 14:26

RNS Number : 9235X
EFG-Hermes Holdings SAE
28 April 2023
 

http://www.rns-pdf.londonstockexchange.com/rns/9235X_1-2023-4-28.pdf

EFG Hermes Reports IFRS Consolidated Financial Statements for the Year Ended 31 December 2022

 

For the full financial Statements please click on the link on top of the page

 

Consolidated statement of financial position

As at 31 December

 

 

2022

2021

EGP

EGP

 

Restated

Assets

Notes

Cash and cash equivalents

5

 26,214,250,479

30,876,257,819

Funded facilities to customers

8

 13,904,711,801

10,454,979,766

Banking loans and facilities (aiBank)

8.1

 19,317,430,427

9,544,916,760

Accounts receivable

7

 5,569,133,136

5,611,375,904

Investments at fair value through profit and loss

6

 6,772,893,362

8,002,539,778

Investments at fair value through OCI

9

 14,080,120,999

16,820,480,365

Investments at amortized cost

12

 11,518,692,377

10,050,278,918

Assets held for sale

11

 349,701,081

310,745,145

Equity accounted investees

10

 606,432,818

461,315,552

Investment properties

13

 118,984,442

125,529,472

Property and equipment

14

 1,636,042,509

1,522,312,110

Goodwill and other intangible assets

15

 1,954,749,801

993,839,079

Deferred tax assets

22

 64,486,447

41,521,424

Other assets

16

 3,401,909,847

2,564,263,111

Total assets

105,509,539,526

 

97,380,355,203

Liabilities

Due to banks and financial institutions

17

 12,371,835,820

17,736,580,111

Customer deposits

18

 48,130,171,764

38,564,737,371

Loan and borrowings

24

 4,996,029,063

5,501,069,487

Creditors and other credit balances

21

 4,982,664,616

3,531,967,772

Accounts payable - customers credit balances FVTPL

19

379,039,443

3,890,060,348

Accounts payable - customers credit balances

 9,595,446,350

8,537,833,096

Issued bonds

20

 500,000,000

550,000,000

Provisions

23

 903,715,808

690,001,941

Current tax liability

 473,873,472

363,572,503

Deferred tax liabilities

22

 800,661,223

410,044,804

Total liabilities

 83,133,437,559

79,775,867,433

Equity

Share capital

25

 5,838,424,030

4,865,353,355

Legal reserve

 867,454,520

840,272,556

Share premium

 1,668,623,811

1,668,623,811

Other reserves

 3,125,555,888

783,420,592

Retained earnings

 7,460,139,693

6,486,918,967

Equity attributable to owners of the Group

 

 

 18,960,197,942

14,644,589,281

Non - controlling interests

26

 3,415,904,025

2,959,898,489

Total equity

 22,376,101,967

17,604,487,770

Total liabilities and equity

105,509,539,526

 

97,380,355,203

 

 

These financial statements were approved and authorised for issue on 28 April 2023 and signed by:

 

 

 

 

 

 

Mona Zulficar

Chairperson

Karim Awad

Group Chief Executive Officer

 

 

 

The accompanying notes form an integral part of these consolidated financial statements.

 

Consolidated statement of profit or loss

For the year ended 31 December

 

 

Notes

2022

 

2021

 

 

EGP

 

EGP

 

 

 

 

Restated

Interest income

32

9,295,888,885

4,416,355,205

Interest expense

32

 (5,698,004,648)

(1,831,314,272)

Net interest income

 

3,597,884,237

 

2,585,040,933

Fee and commission income

32

4,804,815,709

3,395,050,747

Fee and commission expense

32

 (508,239,556)

(344,114,579)

Net fee and commission income

4,296,576,153

 

3,050,936,168

Securities' losses for investments at FVTPL

32

 (847,026,822)

(7,302,092)

Changes in the fair value of investments at FVTPL

6-32

923,031,019

(76,153,571)

Dividend income

32

5,660,968

31,853,072

Other revenues

28

159,190,766

146,867,227

Gains on dereceognition of financial assets at amortized cost

32

222,309,757

88,347,943

Impairment loss on financial assets - net of recoveries

29

 (726,510,890)

(137,995,100)

Foreign currencies exchange differences

32

 2,495,674,925

234,140,416

Gains on selling assets held for sale

32

 5,486,779

3,864,407

Share of proft/(loss) from equity accounted investees

32

 76,562,049

(14,173,369)

Bargain purchase gain

15

 -

97,562,892

 

 

 10,208,838,941

 

6,002,988,926

General and administrative expenses

31

 (6,541,863,982)

(3,796,051,268)

Financial guarantee provision

23

 (21,174,484)

(5,673,313)

Impairment loss on goodwill and intangible assets

32

 (10,239,218)

(16,034,698)

Provisions

23

 (156,889,673)

(96,968,478)

Depreciation and amortisation

31.2

 (296,470,780)

(196,292,200)

Profit before tax

 3,182,200,804

1,891,968,969

Income tax expense

30

 (1,103,724,498)

(350,195,700)

Profit for the year

 2,078,476,306

 

1,541,773,269

Attributable to:

 

 

 

Shareholders of the Holding Company

1,724,108,570

1,425,807,709

Non-controlling interests

354,367,736

115,965,560

2,078,476,306

 

1,541,773,269

 

 

Earnings per share:

 

Basic earning per share - EGP

34

1.48

 

1.27

 

Diluted earnings per share - EGP

34

1.48

 

1.27

 

 

 

The accompanying notes form an integral part of these consolidated financial statements.

 

Consolidated statement of comprehensive income

For the year ended 31 December

 

 

 

Notes

2022

 

2021

 

 

EGP

 

EGP

 

 

 

 

Restated

Profit for the year

 

 2,078,476,306

1,541,773,269

Other comprehensive income items:

Items that may be reclassified to the consolidated statement of profit or loss

Foreign operations - foreign currency translation differences

3,210,783,015

(15,450,147)

Foreign currency translation differences - reclassified to profit or loss

(852,751,863)

(167,306,760)

Net losses on investments in debt instruments at FVOCI- net change in fair value

(157,786,834)

(10,639,480)

Investments at fair value through OCI - net change in fair value - reclassified to profit or loss

(3,015,600)

34,043,158

Tax relating to such items

22

24,443,416

(930,181)

 

2,221,672,134

(160,283,410)

Items that will not be reclassified to the consolidated statement of profit or loss

Investment at fair value through OCI - reclassified to retained Earnings

(547,139)

(15,659)

Net gains on investments in equity instruments designated at fair value through OCI

49,993,934

10,802,502

Share of other comprehensive income of equity accounted investees

206,189

-

Actuarial gain/(loss) re-measurement of employees' benefits obligations

23

(4,505,067)

971,076

Total other comprehensive income for the year

2,266,820,051

(148,525,491)

Total comprehensive income for the year

4,345,296,357

 

1,393,247,778

 

Attributable to:

 

 

 

Shareholders of the Holding Company

3,842,008,839

1,268,728,563

Non-controlling interests

503,287,518

124,519,215

4,345,296,357

 

 1,393,247,778

 

 

 

For further information:

Investor Relations Department

Email: investor-relations@efg-hermes.com

Tel: +20 (0)2 35356710

Fax: +20 (0)2 3535 7017

 

Group Head of Corporate Strategy & Investor Relations - Hanzada Nessim

Email: hnessim@efg-hermes.com

Tel: +20 (0)2 35356502

Fax: +20(0)2 3535 7017

www.efg-hermes.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR SEFFDAEDSEEL
Date   Source Headline
23rd Apr 20248:29 amRNSNotice of AGM
21st Mar 20247:24 amRNSEFG Holding to Monetize Shareholders' Value
20th Mar 20247:52 amRNSAnnual Financial Results FY2023
13th Mar 20248:11 amRNSEFG Holding SMEs Lending License Announcement
6th Dec 202312:54 pmRNSJordan Exit
15th Nov 20237:14 amRNS3Q23 Results
2nd Oct 20237:00 amRNSValU to Launch in Jordan in Early 2024
10th Aug 20237:45 amRNSBoard Summary of Resolutions
10th Aug 20237:37 amRNS2Q2023 Results
11th Jul 20237:23 amRNSBonus shares distribution
24th May 20237:32 amRNS1Q23 Results
24th May 20237:31 amRNSExtraordinary Meeting Summary of Resolutions
24th May 20237:00 amRNS1Q23 Results
15th May 20237:00 amRNSInvitation for 2nd Extraordinary General Meeting
15th May 20237:00 amRNSOrdinary General Meeting Summary of Resolutions
28th Apr 20232:26 pmRNSIFRS Consolidated Financial Statements- FY22
18th Apr 20238:08 amRNSInvitation for The Extraordinary General Meeting
18th Apr 20238:08 amRNSInvitation for The Ordinary General Meeting
12th Apr 20232:11 pmRNSBOD Summary of Resolutions- BOD changes
11th Apr 20238:35 amRNSOman Exit
3rd Apr 20233:11 pmRNSBOD Summary of Resolutions- Bonus Shares
22nd Mar 20237:50 amRNSBOD Summary of Resolutions- FY2022
22nd Mar 20237:41 amRNSFY2022 Results
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
20th Feb 20237:05 amRNSBoard of Directors’ Change
17th Jan 202312:46 pmRNSEFG Hermes Pursue Exit Options from Some Markets
21st Dec 20224:40 pmRNSSecond Price Monitoring Extn
21st Dec 20224:35 pmRNSPrice Monitoring Extension
16th Nov 20227:00 amRNSBOD Summary of Resolutions for 3Q22
16th Nov 20227:00 amRNS3Q2022 Results
1st Nov 202212:41 pmRNSvalU Invests in Live Shopping Platform "Hoods"
19th Oct 20221:53 pmRNSvalU Acquire Minority Stake in Kiwe
22nd Aug 20222:42 pmRNSvalU Acquires 100% of Fintech Company Paynas
17th Aug 20228:13 amRNS2Q2022 Results
16th Aug 20224:40 pmRNSSecond Price Monitoring Extn
16th Aug 20224:35 pmRNSPrice Monitoring Extension
15th Aug 20224:41 pmRNSSecond Price Monitoring Extn
15th Aug 20224:35 pmRNSPrice Monitoring Extension
3rd Aug 20224:41 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
27th Jun 20222:58 pmRNSThe Distribution Date of The Bonus Shares
20th Jun 20228:19 amRNSvalU's Agreement to sell a Minority Stake
15th Jun 20221:53 pmRNSTanmeyah Acquires Tech-Driven B2B Platform Fatura
7th Jun 20228:36 amRNSVortex Energy Invests c.EUR222 million into Ignis
6th Jun 20228:12 amRNSvalU Partnership to Offer Consumer Finance in KSA
1st Jun 20228:21 amRNSEGM Summary of Resolutions
25th May 20228:27 amRNS1Q2022 Results
23rd May 20227:00 amRNSInvitation for the Second EGM
19th May 20228:37 amRNSAGM Summary of Resolutions
17th May 20228:14 amRNSUpdate on valU/Amazon Agreements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.